These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 37349884)
1. Downregulation of AHNAK2 inhibits cell cycle of lung adenocarcinoma cells by interacting with RUVBL1. Li X; Li H; Shao MM; Miao J; Fu Y; Hu B Thorac Cancer; 2023 Aug; 14(22):2093-2104. PubMed ID: 37349884 [TBL] [Abstract][Full Text] [Related]
2. AHNAK2 Is Associated with Poor Prognosis and Cell Migration in Lung Adenocarcinoma. Zhang S; Lu Y; Qi L; Wang H; Wang Z; Cai Z Biomed Res Int; 2020; 2020():8571932. PubMed ID: 32904605 [TBL] [Abstract][Full Text] [Related]
3. Down-Regulation of AHNAK2 Inhibits Cell Proliferation, Migration and Invasion Through Inactivating the MAPK Pathway in Lung Adenocarcinoma. Wang DW; Zheng HZ; Cha N; Zhang XJ; Zheng M; Chen MM; Tian LX Technol Cancer Res Treat; 2020; 19():1533033820957006. PubMed ID: 33000678 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of BCCIP predicts an unfavorable prognosis and promotes the proliferation and migration of lung adenocarcinoma. Shi J; Lv X; Li W; Ming Z; Zeng L; Yuan J; Chen Y; Liu B; Yang S Thorac Cancer; 2021 Sep; 12(17):2324-2338. PubMed ID: 34297484 [TBL] [Abstract][Full Text] [Related]
5. CircMYO10 promotes osteosarcoma progression by regulating miR-370-3p/RUVBL1 axis to enhance the transcriptional activity of β-catenin/LEF1 complex via effects on chromatin remodeling. Chen J; Liu G; Wu Y; Ma J; Wu H; Xie Z; Chen S; Yang Y; Wang S; Shen P; Fang Y; Fan S; Shen S; Fang X Mol Cancer; 2019 Oct; 18(1):150. PubMed ID: 31665067 [TBL] [Abstract][Full Text] [Related]
6. Junctional adhesion molecule-like protein promotes tumor progression via the Wnt/β-catenin signaling pathway in lung adenocarcinoma. Wu Q; Li R; Wang QX; Zhang MY; Liu TT; Qu YQ J Transl Med; 2022 Jun; 20(1):260. PubMed ID: 35672776 [TBL] [Abstract][Full Text] [Related]
7. KIAA1429 promotes the progression of lung adenocarcinoma by regulating the m6A level of MUC3A. Zhao W; Xie Y Pathol Res Pract; 2021 Jan; 217():153284. PubMed ID: 33249400 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients. Feng YY; Liu CH; Xue Y; Chen YY; Wang YL; Wu XZ Gene; 2020 Mar; 730():144316. PubMed ID: 31884109 [TBL] [Abstract][Full Text] [Related]
9. CircPRKCI regulates proliferation, migration and cycle of lung adenocarcinoma cells by targeting miR-219a-5p-regulated CAMK1D. Sui MH; Zhang WW; Geng DM; Sun DJ Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1899-1909. PubMed ID: 33660800 [TBL] [Abstract][Full Text] [Related]
10. Hypoxia-inducible lipid droplet-associated (HILPDA) facilitates the malignant phenotype of lung adenocarcinoma cells in vitro through modulating cell cycle pathways. Sheng Y; Li J; Yang Y; Lu Y Tissue Cell; 2021 Jun; 70():101495. PubMed ID: 33535136 [TBL] [Abstract][Full Text] [Related]
11. Correlation between prognostic indicator AHNAK2 and immune infiltrates in lung adenocarcinoma. Zheng M; Liu J; Bian T; Liu L; Sun H; Zhou H; Zhao C; Yang Z; Shi J; Liu Y Int Immunopharmacol; 2021 Jan; 90():107134. PubMed ID: 33168407 [TBL] [Abstract][Full Text] [Related]
12. Sauchinone: a prospective therapeutic agent-mediated EIF4EBP1 down-regulation suppresses proliferation, invasion and migration of lung adenocarcinoma cells. Li SQ; Feng J; Yang M; Ai XP; He M; Liu F J Nat Med; 2020 Sep; 74(4):777-787. PubMed ID: 32666278 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of ERCC6L correlates with poor prognosis and confers malignant phenotypes of lung adenocarcinoma. Huang X; Jiang L; Lu S; Yuan M; Lin H; Li B; Wen Z; Zhong Y Oncol Rep; 2022 Jul; 48(1):. PubMed ID: 35656882 [TBL] [Abstract][Full Text] [Related]
14. PPP1R14D promotes the proliferation, migration and invasion of lung adenocarcinoma via the PKCα/BRAF/MEK/ERK signaling pathway. Cao H; Wang Z; Wang Y; Ye L; Li R; Xue Y; Li K; Di T; Li T; Fan Z; Liu Y; Guo J; Yao H; Ge C Int J Oncol; 2022 Dec; 61(6):. PubMed ID: 36263632 [TBL] [Abstract][Full Text] [Related]
15. FAM83B promotes the invasion of primary lung adenocarcinoma via PI3K/AKT/NF-κB pathway. Zhang J; Wang J; Yue K; Li P; Shen W; Qiao X; Wang Y; Wu X BMC Pulm Med; 2023 Jan; 23(1):32. PubMed ID: 36690987 [TBL] [Abstract][Full Text] [Related]
16. Downregulation of PTPRT elevates the expression of survivin and promotes the proliferation, migration, and invasion of lung adenocarcinoma. Chen C; Liu H; Li Y; Xu Q; Liu J BMC Cancer; 2024 Jan; 24(1):63. PubMed ID: 38216925 [TBL] [Abstract][Full Text] [Related]
17. Xu M; Wen J; Xu Q; Li H; Lin B; Bhandari A; Qu J Curr Cancer Drug Targets; 2024; 24(2):220-229. PubMed ID: 36089788 [TBL] [Abstract][Full Text] [Related]
18. KANK3 mediates the p38 MAPK pathway to regulate the proliferation and invasion of lung adenocarcinoma cells. Dai Z; Xie B; Yang B; Chen X; Hu C; Chen Q Tissue Cell; 2023 Feb; 80():101974. PubMed ID: 36463587 [TBL] [Abstract][Full Text] [Related]
19. miR-21-5p promotes lung adenocarcinoma cell proliferation, migration and invasion via targeting WWC2. Wang G; Zhou Y; Chen W; Yang Y; Ye J; Ou H; Wu H Cancer Biomark; 2020; 28(4):549-559. PubMed ID: 32623387 [TBL] [Abstract][Full Text] [Related]
20. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway. Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]